Trans-fatty acids killing 5.4 lakh a year: Govt

NEW DELHI : High intake of trans-fatty acids increases the risk of coronary heart disease, Union health minister Mansukh Mandaviya told Lok Sabha on Friday.

In a written reply to a Parliament question, Mandaviya said industrially produced trans-fat is commonly found in packaged foods, baked goods, cooking oil and spreads. “Approximately 5,40,000 deaths each year are estimated to be attributed to the intake of industrially produced trans-fatty acids,” he said. The health minister said that high trans-fat intake may increase the risk of death from any cause by 34%, and coronary heart disease deaths by 28%.
“This is likely due to the effect on lipid levels: trans-fat increases LDL (low-density lipoprotein) or bad cholesterol levels while lowering HDL (high-density lipoprotein) or good cholesterol levels. According to the World Health Organisation, 4.6% of coronary heart disease deaths in India may be related to trans-fatty acid intake ( 0.5% of energy intake),” Mandaviya said.

Food Safety Standard Authority of India (FSSAI) has implemented best-practice policy as specified by WHO to gradually reduce the trans-fats consumption in India.

In this regard, the health minister explained, FSSAI has notified the Food Safety and Standards (Prohibition and Restrictions on Sales) Second Amendment Regulations, 2021, on February 2, 2020, and Food Safety and Standards (Food Products Standards and Food Additives) Tenth Amendment Regulations, 2020, on December 29, 2020, to reduce the maximum limit of industrial trans-fatty acids to not more than 2% by weight in edible oils, fats and food products in which edible oils and fats are used as an ingredient. “These amendments came into effect from January 1, 2022. The changes introduced are in line with recommendations of the World Health Organisation,” he added.

Related Posts

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

New Delhi: Improving access to new age medicines for obesity and diabetes over the next few years would be a key enabler for the growth of the domestic pharmaceutical industry,…

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 37 new drugs in its recent meeting, under the provisions of the Drugs Prices Control Order (DPCO), 2013,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Strides Pharma Science arm New York facility gets 4 USFDA observations

Strides Pharma Science arm New York facility gets 4 USFDA observations

SSI Mantra, Made in India Robot, bats a Thousand by completing 100 Telesurgeries

SSI Mantra, Made in India Robot, bats a Thousand by completing 100 Telesurgeries